Annals of Surgical Oncology, Vol 7, Issue 8 601-608, Copyright © 2000 by Society of Surgical Oncology

ARTICLES

Lymph node micrometastases do not predict relapse in stage II colon cancer

J. Tschmelitsch, D. S. Klimstra and A. M. Cohen
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

BACKGROUND: Over one third of patients with stage II colonic adenocarcinoma experience tumor recurrence. Because effective adjuvant therapy is now available, it is important to identify subsets of patients at higher risk for relapse who may benefit from early treatment. Immunohistochemistry has been used to detect microscopic metastases in histologically uninvolved mesenteric lymph nodes, but the prognostic significance of minimal nodal involvement has not been established. METHODS: Hematoxylin and eosin (H&E)-stained recuts of 900 mesenteric lymph nodes from 55 patients (range, 2-47; mean, 16.4 nodes per case) with resected pT3 or pT4, N0, M0 (TNM stage II) colonic adenocarcinomas were re-examined for the presence of metastases and then stained immunohistochemically for keratin using the AE1:AE3 antibody. Twenty-seven patients did not experience recurrence of tumor within 5 years following resection (no evidence of disease [NED]); 28 patients relapsed during the same time frame. Lymph nodes from 10 patients having colonic resections for nonneoplastic disorders also were stained as controls. Keratin-positive cells and cell clusters were quantified in the lymph nodes, and comparisons were made between patients with and without tumor relapse. RESULTS: In the relapse group, four patients had positive nodes already identified on the H&E-stained recuts and had to be excluded from further analysis. Sixteen additional patients had keratin-positive cells; thus, 16 of 24 (67%) had micrometastases. In the NED group, one patient had a positive node on H&E staining and 22 additional patients had keratin-positive cells, so 22 of 26 (84%) patients had micrometastases. In the patients who had micrometastases, there was a mean of 3.5 and 4.6 positive nodes in the relapse and NED groups, respectively, and a mean of 11.3 and 12.4 keratin-positive cells or clusters in the relapse and NED groups, respectively. No keratin-positive cells were found in the 1 to 21 (mean, 9.1) nodes per case studied in the control patients. CONCLUSIONS: Micrometastases to histologically uninvolved mesenteric lymph nodes commonly are detected in patients with pT3 or pT4 colonic adenocarcinomas on recuts stained immunohistochemically for keratin. Nodal micrometastases detected by immunohistochemical staining are not useful for identifying stage II patients at higher risk for relapse.

This article has been cited by other articles:

				J. J. Bennett, C. R. Schmidt, D. S. Klimstra, S. R. Grobmyer, N. M. Ishill, M. D'Angelica, R. P. DeMatteo, Y. Fong, L. H. Blumgart, and W. R. Jarnagin Perihepatic Lymph Node Micrometastases Impact Outcome after Partial Hepatectomy for Colorectal Metastases Ann. Surg. Oncol., April 1, 2008; 15(4): 1130 - 1136. [Abstract] [Full Text] [PDF]

				C. C. Compton Optimal Pathologic Staging: Defining Stage II Disease Clin. Cancer Res., November 15, 2007; 13(22): 6862s - 6870s. [Abstract] [Full Text] [PDF]

				D. G. Nicastri, J. T. Doucette, T. E. Godfrey, and S. J. Hughes Is Occult Lymph Node Disease in Colorectal Cancer Patients Clinically Significant?: A Review of the Relevant Literature J. Mol. Diagn., November 1, 2007; 9(5): 563 - 571. [Abstract] [Full Text] [PDF]

				C. Coutant, O. Morel, Y. Delpech, S. Uzan, E. Darai, and E. Barranger Laparoscopic Sentinel Node Biopsy in Cervical Cancer Using a Combined Detection: 5 Years Experience Ann. Surg. Oncol., August 1, 2007; 14(8): 2392 - 2399. [Abstract] [Full Text] [PDF]

				R. J. de Haas, D. A. Wicherts, M. G. G. Hobbelink, I. H. M. B. Rinkes, M. E. I. Schipper, J.-A. van der Zee, and R. van Hillegersberg Sentinel Lymph Node Mapping in Colon Cancer: Current Status Ann. Surg. Oncol., March 1, 2007; 14(3): 1070 - 1080. [Abstract] [Full Text] [PDF]

				D. Iddings, A. Ahmad, D. Elashoff, and A. Bilchik The Prognostic Effect of Micrometastases in Previously Staged Lymph Node Negative (N0) Colorectal Carcinoma: A Meta-analysis Ann. Surg. Oncol., November 1, 2006; 13(11): 1386 - 1392. [Abstract] [Full Text] [PDF]

				C Mescoli, M Rugge, S Pucciarelli, V M Russo, G Pennelli, M Guido, and D Nitti High prevalence of isolated tumour cells in regional lymph nodes from pN0 colorectal cancer J. Clin. Pathol., August 1, 2006; 59(8): 870 - 874. [Abstract] [Full Text] [PDF]

				A. J. Bilchik, M. DiNome, S. Saha, R. R. Turner, D. Wiese, M. McCarter, D. S. B. Hoon, and D. L. Morton Prospective Multicenter Trial of Staging Adequacy in Colon Cancer: Preliminary Results Arch Surg, June 1, 2006; 141(6): 527 - 534. [Abstract] [Full Text] [PDF]

				M. Redston, C. C. Compton, B. W. Miedema, D. Niedzwiecki, J. M. Dowell, S. D. Jewell, J. M. Fleshman, J. Bem, R. J. Mayer, and M. M. Bertagnolli Analysis of Micrometastatic Disease in Sentinel Lymph Nodes From Resectable Colon Cancer: Results of Cancer and Leukemia Group B Trial 80001 J. Clin. Oncol., February 20, 2006; 24(6): 878 - 883. [Abstract] [Full Text] [PDF]

				S. B. Ho, A. Hyslop, R. Albrecht, A. Jacobson, M. Spencer, D. A. Rothenberger, G. A. Niehans, J. D'Cunha, and R. A. Kratzke Quantification of Colorectal Cancer Micrometastases in Lymph Nodes by Nested and Real-Time Reverse Transcriptase-PCR Analysis for Carcinoembryonic Antigen Clin. Cancer Res., September 1, 2004; 10(17): 5777 - 5784. [Abstract] [Full Text] [PDF]

				L. F. Onate-Ocana, R. Montesdeoca, C. M. Lopez-Graniel, V. Aiello-Crocifoglio, R. Mondragon-Sanchez, M. Cortina-Borja, R. Herrera-Goepfert, C. Oros-Ovalle, and D. Gallardo-Rincon Identification of Patients with High-risk Lymph Node-negative Colorectal Cancer and Potential Benefit from Adjuvant Chemotherapy Jpn. J. Clin. Oncol., June 1, 2004; 34(6): 323 - 328. [Abstract] [Full Text] [PDF]

				F. L. Greene, A. K. Stewart, and H. J. Norton New Tumor-Node-Metastasis Staging Strategy for Node-Positive (stage III) Rectal Cancer: An Analysis J. Clin. Oncol., May 15, 2004; 22(10): 1778 - 1784. [Abstract] [Full Text] [PDF]

				R. J. Feezor, E. M. Copeland III, and S. N. Hochwald Significance of Micrometastases in Colorectal Cancer Ann. Surg. Oncol., December 1, 2002; 9(10): 944 - 953. [Full Text] [PDF]

				M. R. Weihrauch, E. Skibowski, T. C. Koslowsky, W. Voiss, D. Re, F. Kuhn-Regnier, C. Bannwarth, M. Siedek, V. Diehl, and H. Bohlen Immunomagnetic Enrichment and Detection of Micrometastases in Colorectal Cancer: Correlation With Established Clinical Parameters J. Clin. Oncol., November 1, 2002; 20(21): 4338 - 4343. [Abstract] [Full Text] [PDF]

				J. H. Wong, S. Steinemann, P. Tom, S. Morita, and P. Tauchi-Nishi Volume of Lymphatic Metastases Does Not Independently Influence Prognosis in Colorectal Cancer J. Clin. Oncol., March 15, 2002; 20(6): 1506 - 1511. [Abstract] [Full Text] [PDF]

				R. Rosenberg, A. Hoos, J. Mueller, P. Baier, D. Stricker, M. Werner, H. Nekarda, and J.-R. Siewert Prognostic Significance of Cytokeratin-20 Reverse Transcriptase Polymerase Chain Reaction in Lymph Nodes of Node-Negative Colorectal Cancer Patients J. Clin. Oncol., February 15, 2002; 20(4): 1049 - 1055. [Abstract] [Full Text] [PDF]

				S. Andreola, E. Leo, F. Belli, G. Gallino, G. Sirizzotti, and G. Sampietro Adenocarcinoma of the Lower Third of the Rectum: Metastases in Lymph Nodes Smaller Than 5 mm and Occult Micrometastases; Preliminary Results on Early Tumor Recurrence Ann. Surg. Oncol., June 1, 2001; 8(5): 413 - 417. [Abstract] [Full Text] [PDF]